isoSolutions provides a one-stop shopping service as well as technical support worldwide for nuclear medicine applications including: Radiochemicals, Stable isotopes, Labeled compounds, Sealed sources, Synthesizers and Peptides. We provide a complete range of Radioisotopes, including a Ga-68 Generator, Lu-177, Y-90, a Re-188 Generator, I-131, I-125 and cyclotron products.
These products are complemented by an automated labeling module for development work or preprogrammed syntheses and a complete line of quality control instruments. We also offer consulting services for radiochemistry, grant applications and licensing (CMC sections, INDs, DMFs) in several regions of the globe.
To offer products, services and solutions to the nuclear medicine, radioisotope research, pharmaceutical and medical device industries and providing a connection to an extensive network of suppliers and resources.
To become a model organization for delivery of nuclear medicine products, widely recognized for our reliability and excellent customer service.
isoSolutions believes the principles that form the bedrock of a business relationship are critical.
Especially within an intimate industry like nuclear medicine, a client can feel confident that a contract with isoSolutions is a matter between isoSolutions and the client, and will not be communicated to competitors or other companies in the industry. A standard mutual non-disclosure agreement will be signed on request, but confidentiality will be respected with or without a formal agreement.
You can expect honest answers to questions and honest assessments of what can be provided by isoSolutions and what cannot be provided. An order will not be accepted unless it can be fulfilled with excellence. Integrity is our most important business principle.
There are no standard projects for isoSolutions; each project is dictated by the client. For any project, realistic timetables will be provided in advance, and you can rely on the deadlines. If more time is required to provide you with the best information, this will be discussed well in advance of the deadline.
If there is dissatisfaction with a product or delivery, isoSolutions will work hard to “make it right.”
Founded isoSolutions Inc. (consulting company).
Founded isoSolutions Marketing & Management Inc.
(product distribution company).
isoSolutions was co-founder of Cyclomedical Applications Group, a company providing medical cyclotron facility services and contract management.
isoSolutions was co-founder of Alpha IICH Inc., a company developing a supply of alpha emitting radioisotopes for radiotherapy.
Established Area Sales Manager for Latin American market.
Formed partnership with Vira Pharma GmbH, a German company that managed the European market while isoSolutions managed the North and South American markets.
Headquarters of isoSolutions moved from Ottawa, Ontario to Vancouver, British Columbia.
Appointed Marketing & Sales Manager, Asia.
Initiated marketing activities in China.
First exhibit at Society of Nuclear Medicine and Molecular Imaging Annual Meeting (Miami Beach).
Hired Executive Assistant to Managing Director.
Established new office space in West End of Vancouver.
Hired Marketing & Sales Manager, Latin America.
isoSolutions sponsors an annual Armstrong-Lepeska Science Marketing Scholarship at Langara College.
Hired Marketing & Sales Manager, Canada/USA.
First exhibit at Canadian Association of Nuclear Medicine (Calgary).
First exhibit at international congress (World Federation of Nuclear Medicine & Biology, Cancun).
First ALASBIMN exhibit (Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear, Punta del Este).
Established Order Desk.
First exhibit at Brazilian Congress of Nuclear Medicine and Biology (Rio de Janeiro).
isoSolutions celebrates 15th Anniversary.
isoSolutions launches re-designed web site
isoSolutions adds Elysia-raytest to product line
isoSolutions establishes first sales and marketing manager located in United States
A Customer Service Manager is appointed with responsibility for supplier and customer relations, order management, and logistics.
isoSolutions appoints Directors of Marketing & Sales, Customer Service and Administration
GMP grade non-carrier added Lutetium-177 is added to the product portfolio.
A new strategic commercial alliance is established with Fenix Medica to strengthen our presence in Latin America.
A Sales & Marketing Manager for Asia is appointed, expanding the Asian team to three staff.
isoSolutions exhibits at the International Symposium on Targeted Alpha-Therapy.
isoSolutions attends the Chinese National Conference of Nuclear Medicine.
isoSolutions joins the Canadian Nuclear Isotope Council.
Founder started transition to retirement as Strategic Consultant, and new Managing Director was appointed.
The infographic below is meant to inform and clarify the areas for which isoSolutions supplies products to the Nuclear Medicine World.